Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
100%
Infectious Disease
100%
Antibiotic Resistance
46%
Plasmid
43%
Escherichia coli
41%
Minimum Inhibitory Concentration
36%
Neisseria gonorrhoeae
35%
Whole Genome Sequencing
33%
Prevalence
30%
Antibiotic Sensitivity
30%
Serotype
30%
Lineages
29%
Susceptibility
28%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Methicillin-Resistant Staphylococcus Aureus
25%
Staphylococcus Aureus
24%
Klebsiella pneumoniae
21%
Pseudomonas aeruginosa
20%
COVID-19
19%
Single Nucleotide Polymorphism
19%
Bacterium
18%
Antimicrobial Agent
16%
Infectious Agent
15%
Cladistics
14%
Multilocus Sequence Typing
14%
Genome Sequencing
14%
Streptococcus Pneumonia
13%
Salmonella enterica
13%
Acinetobacter Baumannii
13%
Cohort Effect
12%
Salmonella
12%
Epidemiology
12%
Gram-Negative Bacteria
12%
Staphylococcus Capitis
12%
Carbapenemase Producing Enterobacteriaceae
12%
Enterobacterales
12%
Allele
11%
Tandem Repeat
10%
Enterobacteriaceae
10%
Multiplex Polymerase Chain Reaction
9%
Colistin
8%
Acinetobacter
8%
Real Time Polymerase Chain Reaction
8%
Urinary Tract
8%
Molecular Epidemiology
7%
Klebsiella
7%
Chlamydia Trachomatis
7%
Polymerase Chain Reaction
6%
Enterobacter Cloacae
6%
In Vitro
6%
Salmonella Enterica Serovar Typhimurium
6%
Multidrug Resistance
6%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Replicon
6%
Candida Auris
5%
Ribosomal RNA
5%
Penicillin
5%
Antimicrobial Resistance Genes
5%
Agar Dilution
5%
Biofilm
5%
Bioinformatics
5%
Ebola Virus
5%
Soft Tissue
5%
Integron
5%
Salmonella Enterica Serovar Enteritidis
5%
Keyphrases
United Kingdom
49%
Antimicrobial Resistance
43%
COVID-19
39%
Healthcare Workers
24%
Whole Genome Sequencing
22%
Neisseria Gonorrhoeae
20%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
19%
Escherichia Coli
18%
Plasmid
16%
Epidemiology
15%
Antibiotic Prescribing
14%
Staphylococcus
14%
Antibiotics
14%
Group A Streptococcus
13%
Meticillin-resistant Staphylococcus Aureus
13%
Wales
12%
Surveillance Program
12%
Pseudomonas Aeruginosa (P. aeruginosa)
12%
Europe
12%
Carbapenemase Genes
11%
Methicillin-resistant Staphylococcus Aureus
11%
Pulsed-field Gel Electrophoresis
11%
Ciprofloxacin
11%
Siren
11%
Bacteremia
11%
Infection Prevention
11%
Sequence Type
11%
Risk Factors
11%
Ebola Virus Disease
10%
Molecular Epidemiology
10%
Antibiotic Use
10%
Carbapenemase-producing Enterobacteriaceae
10%
Primary Care
10%
Neonatal Unit
10%
Gene Encoding
10%
Acinetobacter Baumannii (A. baumannii)
9%
SARS-CoV-2 Infection
9%
Core Genome multilocus Sequence Typing (cgMLST)
9%
Antimicrobial Susceptibility
9%
95% Confidence Interval
9%
Infection Control
9%
Variable number Tandem Repeat
8%
Klebsiella Pneumoniae (K. pneumoniae)
8%
European Economic Area
8%
Escherichia Coli Bacteremia
8%
Antimicrobial
8%
Acute Hospital
8%
N. Gonorrhoeae
8%
Carbapenemases
8%
OXA-48
8%
Healthcare-associated Infections
8%
Acinetobacter
8%
Antibiotic Resistance
8%
Quantitative PCR
8%
BlaOXA
8%
Enterobacteriaceae
8%
Neonate
7%
Cystic Fibrosis
7%
Public Health England
7%
Streptococcus Pneumoniae
7%
Multiplex PCR (mPCR)
7%
European Union
7%
People Who Inject Drugs
7%
Health Inequalities
7%
Antimicrobial Resistance Surveillance
7%
Decontamination
7%
Antimicrobial Surveillance
7%
Vaccination
7%
Antimicrobial Use
6%
Meta-analysis
6%
Surveillance System
6%
Gonorrhea
6%
Influenza
6%
Streptococcus Pyogenes (S. pyogenes)
6%
Azithromycin
6%
Urinary Tract Infection
6%
Ireland
6%
Soft Tissue Infection
6%
Multidrug-resistant
6%
Hansen's Disease
6%
Gram-negative Bacteria
6%
Point Prevalence Survey
6%
Carbapenemase
6%
Salmonella Enterica
6%
Mycobacterium Tuberculosis (M. tb)
6%
Carbapenemase-producing
6%
Surveillance Data
6%
Chlamydia Trachomatis
6%
Leprosy
6%
Carbapenemase-producing Enterobacterales
5%
Candida Auris
5%
Staphylococcus Capitis
5%
Rapid Identification
5%
National Surveillance
5%
Clinically Significant
5%
Healthcare Professionals
5%
Ceftriaxone
5%
Healthcare
5%
Carbapenem Resistance
5%
Sepsis
5%
Medicine and Dentistry
Infection
60%
COVID-19
34%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Antibiotic Resistance
33%
Health Care Personnel
28%
Public Health
20%
Antimicrobial Agent
19%
Diseases
18%
Bloodstream Infection
18%
Methicillin Resistant Staphylococcus Aureus
18%
Prevalence
17%
Infection Control
16%
Cohort Effect
15%
Escherichia coli
15%
Systematic Review
15%
Antibiotics
14%
Whole Genome Sequencing
14%
Ebolavirus
13%
Virus Infection
12%
Pathogen
12%
Cohort Analysis
10%
Infection Prevention
10%
Global Disease Burden
10%
Genetics
10%
Neonate
9%
Reinfection
9%
Streptococcus Group A
9%
Tuberculosis
9%
Influenza
9%
Human Immunodeficiency Virus
8%
Neisseria gonorrhoeae
8%
Antiinfective Agent
8%
Group A Streptococcal Infection
8%
Healthcare Associated Infection
7%
Health Inequality
7%
Carbapenemase
6%
Respiratory Tract Infection
6%
Polymerase Chain Reaction
6%
Beta-Lactamase
6%
Pseudomonas aeruginosa
6%
National Health Service
6%
Staphylococcus Aureus
6%
Single Nucleotide Polymorphism
6%
Urinary Tract Infection
6%
Intensive Care Unit
6%
Antimicrobial Stewardship
5%
Observational Study
5%
Surveillance System
5%
COVID-19 Vaccine
5%
Streptococcus Agalactiae
5%
Evaluation Study
5%
Antibiogram
5%
Streptococcus Pneumonia
5%
Meta-Analysis
5%
Gram-Negative Bacteria
5%
Methicillin Susceptible Staphylococcus Aureus
5%
Oral
5%
Pneumococcal Pneumonia
5%